Sara H. Hazem

Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis

Rasha Abdelhady, Sameh Saber, Mustafa Ahmed Abdel‐Reheim et al. · Frontiers in Pharmacology · 2023 · 40 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Escin suppresses immune cell infiltration and selectively modulates Nrf2/HO-1, TNF-α/JNK, and IL-22/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice

Mahmoud Elshal, Sara H. Hazem · Inflammopharmacology · 2022 · 31 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

The novel Janus kinase inhibitor ruxolitinib confers protection against carbon tetrachloride-induced hepatotoxicity via multiple mechanisms

Sara H. Hazem, Mohamed E. Shaker, Sylvia A. Ashamallah et al. · Chemico-Biological Interactions · 2014 · 22 citations

Veterinary Medicine, Pharmacology, Toxicology +14

Inhibition of the JAK/STAT pathway by ruxolitinib ameliorates thioacetamide-induced hepatotoxicity

Mohamed E. Shaker, Sara H. Hazem, Sylvia A. Ashamallah · Food and Chemical Toxicology · 2016 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis

Sara H. Hazem, Mohamed F. Hamed, Mohamed Saad et al. · International Immunopharmacology · 2018 · 20 citations

Pharmacy, Biochemistry, Pharmacology +7